Rovalpituzumab
Modify Date: 2025-10-11 02:02:04
Rovalpituzumab structure
|
Common Name | Rovalpituzumab | ||
|---|---|---|---|---|
| CAS Number | 1613313-01-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RovalpituzumabRovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine[1]. Rovalpituzumab has activity against small cell lung cancer (SCLC)[1]. |
| Name | Rovalpituzumab |
|---|
| Description | Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine[1]. Rovalpituzumab has activity against small cell lung cancer (SCLC)[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |